Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

763 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.
Peccatori J, Barkholt L, Demirer T, Sormani MP, Bruzzi P, Ciceri F, Zambelli A, Da Prada GA, Pedrazzoli P, Siena S, Massenkeil G, Martino R, Lenhoff S, Corradini P, Rosti G, Ringden O, Bregni M, Niederwieser D; European Bone Marrow Transplantation Solid Tumor Working Party. Peccatori J, et al. Among authors: ringden o. Cancer. 2005 Nov 15;104(10):2099-103. doi: 10.1002/cncr.21477. Cancer. 2005. PMID: 16220555 Free article.
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A. Champlin RE, et al. Among authors: ringden o. Blood. 2000 Jun 15;95(12):3702-9. Blood. 2000. PMID: 10845900 Free article. Clinical Trial.
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation.
Barkholt L, Hentschke P, Zetterquist H, Mattsson J, Uzunel M, Wersäll P, Martola J, Albin N, Aschan J, Wijkström H, Tillegård A, Oman S, Wernerson A, Niederwieser D, Thörne A, Ringdén O. Barkholt L, et al. Among authors: ringden o. Transplant Proc. 2001 Feb-Mar;33(1-2):1862-4. doi: 10.1016/s0041-1345(00)02726-3. Transplant Proc. 2001. PMID: 11267544 No abstract available.
Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors.
Ljungman P, Larsson K, Kumlien G, Aschan J, Barkholt L, Gustafsson-Jernberg A, Lewensohn-Fuchs I, Ringdén O. Ljungman P, et al. Among authors: ringden o. Scand J Infect Dis. 2002;34(5):347-50. doi: 10.1080/00365540110080412. Scand J Infect Dis. 2002. PMID: 12069017
763 results